Gillen, J., Mills, K. A., Dvorak, J., Zheng, B., Thai, T., Salani, R., … Moore, K. N. (2017). Imaging Biomarkers of Adiposity and Sarcopenia as Potential Predictors for Overall Survival Among Patients with Endometrial Cancer Treated with Bevacizumab. In Gynecologic Oncology (Vol. 147, pp. 198–199). Elsevier BV. https://doi.org/10.1016/j.ygyno.2017.07.031

Gillen, J., K. A. Mills, J. Dvorak, B. Zheng, T. Thai, R. Salani, C. M. Cosgrove, B. Davidson, P. H. Thaker, and K. N. Moore. “Imaging Biomarkers of Adiposity and Sarcopenia as Potential Predictors for Overall Survival Among Patients with Endometrial Cancer Treated with Bevacizumab.” In Gynecologic Oncology, 147:198–99. Elsevier BV, 2017. https://doi.org/10.1016/j.ygyno.2017.07.031.

Gillen J, Mills KA, Dvorak J, Zheng B, Thai T, Salani R, et al. Imaging Biomarkers of Adiposity and Sarcopenia as Potential Predictors for Overall Survival Among Patients with Endometrial Cancer Treated with Bevacizumab. In: Gynecologic Oncology. Elsevier BV; 2017. p. 198–9.

Gillen, J., et al. “Imaging Biomarkers of Adiposity and Sarcopenia as Potential Predictors for Overall Survival Among Patients with Endometrial Cancer Treated with Bevacizumab.” Gynecologic Oncology, vol. 147, no. 1, Elsevier BV, 2017, pp. 198–99. Crossref, doi:10.1016/j.ygyno.2017.07.031.

Gillen J, Mills KA, Dvorak J, Zheng B, Thai T, Salani R, Cosgrove CM, Davidson B, Thaker PH, Moore KN. Imaging Biomarkers of Adiposity and Sarcopenia as Potential Predictors for Overall Survival Among Patients with Endometrial Cancer Treated with Bevacizumab. Gynecologic Oncology. Elsevier BV; 2017. p. 198–199.